Navigation Links
Unilens Vision Reports Record Third Quarter Revenue, and Royalty Income
Date:5/27/2009

EARNINGS ESCALATE 21% TO $.10 PER DILUTED SHARE

LARGO, Fla., May 27 /PRNewswire-FirstCall/ -- Unilens Vision Inc. (OTC Bulletin Board: UVICF; TSX Venture Exchange: UVI), which develops, licenses, manufactures, distributes and markets specialty contact lenses, today reported its operating results for the third quarter ended March 31, 2009 (FY2009).

Net sales, excluding royalty income, increased 2% to $1,701,043 in the FY2009 third quarter, compared with $1,668,397 in the previous year third quarter (FY2008). The increase was primarily a result of continued growth of the Company's C-Vue brand disposable specialty contact lenses, sold exclusively to licensed eye care professionals.

FY2009 third quarter net income was $446,850, compared with $368,730 in the previous year third quarter, an increase of 21%.

Royalty income for the FY2009 third quarter increased 16.7% to a record third quarter of $734,249 compared with $628,993 in the prior-year quarter. Sales of licensed products by our licensee Bausch & Lomb continue to increase, resulting in continued royalty income growth.

FY2009 third quarter income before taxes increased 18.1% to a record third quarter of $745,249 compared with $631,193 in the prior-year quarter. After recording net income tax expense of $298,399, Unilens reported net income of $446,850 for the quarter, or $0.10 per diluted share. In the FY2008 third quarter, the Company reported net income of $368,730, or $0.08 per diluted share, which included income tax expense of $262,463.

"We are very pleased with our third quarter results, considering the current economic environment," stated Michael J. Pecora, Chief Executive Officer of Unilens Vision Inc. "Double-digit growth from our C-Vue brand of lenses sold exclusively to independent practitioners, combined with a 17% growth in royalty revenue derived from Bausch & L
'/>"/>

SOURCE Unilens Vision Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
2. Unilens Vision Reports Record Second Quarter Revenue, and Royalty Income
3. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
4. Unilens Vision Acquires Aero Contact Lens, Inc.
5. Unilens Vision Reports Record First Quarter Revenue, Earnings and Royalty Income
6. Unilens Launches New C-VUE(R) Advanced(TM) Custom Toric Lens
7. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
8. Unilens Vision Announces New Policies Aimed at Increasing Eye Care Professionals Profitability
9. Unilens Vision Reports Increased Royalty Income
10. Unilens Launches Aspheric C-VUE(R) Daily Disposable Lens
11. Unilens Vision Inc. Declares Regular Quarterly Cash Dividend of U.S. $0.09 Per Share
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... HealthDay Reporter , , THURSDAY, May 23 (HealthDay News) -- ... especially among Hispanic teens, according to a new government report. ... to 19 dropped by nearly one half from 1991 to ... to 31 births for every 1,000. From 2007 to ... percent, from 41.5 to about 31. During that time, ...
(Date:5/23/2013)... May 23 (HealthDay News) -- Although a study ... the thinking and memory problems associated with Alzheimer,s ... have been unable to duplicate those findings. ... implications for patient safety since the drug involved ... effects, such as major blood-lipid abnormalities, pancreatitis, headaches, ...
(Date:5/23/2013)... news release is available in French . ... researchers have discovered a novel molecular mechanism that can ... diseases of abnormal growth. In the May 23 edition ... the University of Montreal explain how they found that ... prevents cells from dividing. , "Cells normally monitor the ...
(Date:5/23/2013)... Six innovative research projects have been awarded ... Alliance, the nation's largest private nonprofit funder of Lyme disease ... the epidemiology of, and treatment and cure for Lyme ... to support the innovative research being conducted by some ... in the field today,” said Harriet Kotsoris, MD, LRA’s ...
(Date:5/23/2013)... May 23, 2013 Applied PilotFish ... today that it has added support for the Direct ... the eiConsole for Healthcare. In addition to the product’s ... LLP, FTP, and Web Services, it now offers support ... Protocol is a specification of the Direct Project ...
Breaking Medicine News(10 mins):Health News:U.S. Teen Birth Rate Plummets: Report 2Health News:U.S. Teen Birth Rate Plummets: Report 3Health News:Scientists Can't Replicate Surprising Finding on Alzheimer's Treatment 2Health News:Scientists discover how rapamycin slows cell growth 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 2Health News:Six Investigators Awarded Lyme Research Alliance Grants 3Health News:Six Investigators Awarded Lyme Research Alliance Grants 4Health News:PilotFish Expand’s Healthcare Integration Capabilities with Support for the New Direct Protocol in Its Latest Product Release 2
... in the June issue of the Journal of ... the university recruitment strategy and process could raise the ... suggests that specific procedural steps could assist in identifying ... surgery departments. , Despite equaling or exceeding ...
... 2008) The American College of Emergency Physicians (ACEP) ... of Emergency Medicine," an honor the organization bestows upon ... medicine, their communities and their patients. , Dr. ... at Harbor-UCLA Medical Center (LA BioMed) researcher to be ...
... 80 years have passed since the German scientist Hans ... for the field of embryonic development. After dividing a ... specifically, the half that gives rise to the ... other ,back, (dorsal) half that develops into its head, ...
... still to really pan out, expert warns , , THURSDAY, June ... developed an immune response to an investigational vaccine lived twice ... new research shows. , "If you were an immune responder, ... author Dr. Susan Domchek, an associate professor of medicine at ...
... Superior Efficacy to Avastin at Improving Visual Acuity When, ... Percent Patient Share, ... from Decision Resources, WALTHAM, Mass., June 26 ... firms focusing on pharmaceutical and,healthcare issues, finds that Genentech/Novartis,s ...
... June 26 ACM today announced the ... as the company,s new,Executive Vice President of ... operations, and client service management, Ms.,Bryngelson will ... of,ACM,s infrastructure -- including technology, call center ...
Cached Medicine News:Health News:Improving university recruitment process may increase female surgical faculty, study finds 2Health News:LA BioMed researcher named 'Hero of Emergency Medicine' 2Health News:Weizmann Institute scientists discover how an injured embryo can regenerate itself 2Health News:Breast Cancer Vaccines Look Promising 2Health News:Breast Cancer Vaccines Look Promising 3Health News:Because of Its Ability to Generate Higher Total Sales in the United States and Europe, Lucentis Will Earn Clinical Gold Standard Status by 2011 for the Treatment of Diabetic Retinopathy 2Health News:ACM Adds Top Industry Executive to Its Leadership Team 2
(Date:5/23/2013)... , May 23, 2013 Israel ... Israel 2013 , Israel,s 1 st ... October 14 th -15 th in Tel ... most innovative city in the world by the Wall ... BrainTech Israel 2013 will showcase the latest breakthroughs ...
(Date:5/23/2013)... -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ) (Intercept), ... and commercialization of novel bile acid therapeutics to treat ... announced that Mark Pruzanski , MD, ... Deutsche Bank Securities 38th Annual Health Care Conference in ... 2013 at 4:10 p.m. ET. About Intercept ...
(Date:5/23/2013)... 23, 2013  MedVantx, Inc., the company that has ... announced today the Company has completed a major expansion ... pharmaceutical products and the upgrade of its systems to ... in its specialty home delivery pharmacy in ... pharmaceutical manufacturers, physicians, health systems and payors novel distribution ...
Breaking Medicine Technology:Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 2Israel Brain Technologies Announces Israel's 1st International Brain Technology Conference 3MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 2MedVantx Achieves Significant Milestone of Managing $1.5B in Prescription Medications and Completes Facilities Expansion While Upgrading To Offer Current Good Manufacturer Practices (cGMP)-level Quality Systems in their Home Delivery Pharmacy 3
... multichannel pipettes speed up ... into microplates, with super ... volumes. The improved ergonomic ... multichannels, combined with super ...
... The Research pro Electronic Pipette is ... the laboratory. Its easy-to-follow display, ergonomically-placed operating ... pipetting, dispensing, reverse pipetting and diluting make ... the simple functions of a manual pipette ...
The Biopette E has a comfortable, ergonomic design. Fully motorized piston drive. Virtually eliminates pipetting forces. User-friendly operator interface. Simple, precise volume setting. Rechargelabl...
... best value in high performance electronic pipetting!, ... design reduce hand fatigue and strain , ... ejector , Color coding for easy volume ... greater performance use Hamilton AdvanTip Low Retention ...
Medicine Products: